In a preclinical study, CD138-based chimeric antigen receptor T cells (CAR-T) also demonstrated significant killing of MM cells, without off tumor cytotoxicity against normal epithelial or endothelial cells27. The gene discussed is SDC1; the disease is Miyoshi myopathy.